Dr. David Bauer is a biomedical chemist specializing in radiopharmaceutical cancer research, mainly targeted alpha-particle therapy (TAT).
He earned his bachelor's degree in biomedical chemistry at the Johannes Gutenberg-University Mainz (Germany, 2014), graduated in chemistry, and obtained his Ph.D. at the Dresden University of Technology (Germany, 2020). He joined the Laboratory of Prof. Jason Lewis (Emily Tow Jackson Chair in Oncology) at the Memorial Sloan Kettering Cancer Center as a research fellow in 2020.